- Filed
- Feb 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jan 30, 2025 | 14.71M sh |
| Short Term Investments | Q2 2025 · Dec 29, 2024 | $6.05M |
| Short Term Investments | Q2 2025 · Jun 30, 2024 | $4.95M |
| Cash And Equivalents | Q2 2025 · Dec 29, 2024 | $2.87M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $2.89M |
| Current Liabilities | Q2 2025 · Dec 29, 2024 | $1.44M |
| Current Liabilities | Q2 2025 · Jun 30, 2024 | $2.02M |
| Total Liabilities | Q2 2025 · Dec 29, 2024 | $2.34M |
| Total Liabilities | Q2 2025 · Jun 30, 2024 | $3.12M |
| Current Assets | Q2 2025 · Dec 29, 2024 | $10.35M |
| Current Assets | Q2 2025 · Jun 30, 2024 | $9.54M |
| Total Assets | Q2 2025 · Dec 29, 2024 | $16.12M |
| Total Assets | Q2 2025 · Jun 30, 2024 | $15.82M |
| Shares Diluted | Q2 2025 · Dec 24, 2023 | 14.47M sh |
| Shares Diluted | Q2 2025 · Dec 24, 2023 | 14.32M sh |
| Capex | Q2 2025 · Dec 24, 2023 | $38K |
| Operating Cash Flow | Q2 2025 · Dec 24, 2023 | $305K |
| Stockholders Equity | Q2 2025 · Dec 24, 2023 | $11.1M |
| Stockholders Equity | Q2 2025 · Sep 24, 2023 | $10.86M |
| Stockholders Equity | Q2 2025 · Jun 25, 2023 | $10.39M |
| Eps Diluted | Q2 2025 · Dec 24, 2023 | $0.04 |
| Eps Diluted | Q2 2025 · Dec 24, 2023 | $0.07 |
| Eps Basic | Q2 2025 · Dec 24, 2023 | $0.04 |
| Eps Basic | Q2 2025 · Dec 24, 2023 | $0.07 |
| Sga Expense | Q2 2025 · Dec 24, 2023 | $1.34M |
| Sga Expense | Q2 2025 · Dec 24, 2023 | $2.66M |
| Net Income | Q2 2025 · Dec 24, 2023 | $553K |
| Net Income | Q2 2025 · Dec 24, 2023 | $939K |
| Net Income | Q2 2025 · Sep 24, 2023 | $386K |
| Revenue restated | Q2 2025 · Dec 24, 2023 | $2.75M |
| Revenue restated | Q2 2025 · Dec 24, 2023 | $5.83M |